(Q28365998)

English

In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii

scientific article

In more languages

Statements

scholarly article

0 references

In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii (English)

0 references

Mycobacterium tuberculosis

0 references

author name string

J D Gay

1

0 references

D R DeYoung

2

0 references

G D Roberts

3

0 references

language of work or name

0 references

publication date

July 1984

0 references

Antimicrobial Agents and Chemotherapy

0 references

26

0 references

1

0 references

94-6

0 references

In vitro susceptibility of Mycobacterium fortuitum to cefoxitin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=179925

29 September 2017

Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=179925

29 September 2017

Comparative in vitro activity of Mk-0366 and other selected oral antimicrobial agents against Neisseria gonorrhoeae

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=179925

29 September 2017

Comparative in vitro activity of norfloxacin (MK-0366) and ten other oral antimicrobial agents against urinary bacterial isolates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=179925

29 September 2017

In vitro antibacterial activity of norfloxacin (MK-0366).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=179925

29 September 2017

Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=179925

29 September 2017

Pulmonary mycobacterial infections due to Mycobacterium intracellulare-avium complex. Clinical features and course in 100 consecutive cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=179925

29 September 2017

Nontuberculous mycobacteria and associated diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=179925

29 September 2017

Identification of Clinical Isolates of Mycobacteria with Gas-Liquid Chromatography Alone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=179925

29 September 2017

In Vitro Susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to Amikacin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=179925

2 June 2018

Long-term results of medical treatment in Mycobacterium intracellulare infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/6236748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the antibacterial activity of norfloxacin (MK 0366, AM 715), a new organic acid, with that of other orally absorbed chemotherapeutic agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/6236748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sulfonamide Activity Against Mycobacterium fortuitum and Mycobacterium chelonei

1 reference

https://pubmed.ncbi.nlm.nih.gov/6236748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Norfloxacin and the antibacterial gamma pyridone beta carboxylic acids

1 reference

https://pubmed.ncbi.nlm.nih.gov/6236748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid

1 reference

https://pubmed.ncbi.nlm.nih.gov/6236748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative in vitro activity of norfloxacin against urinary tract pathogens

1 reference

https://pubmed.ncbi.nlm.nih.gov/6236748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of norfloxacin in healthy volunteers and patients with renal and hepatic damage

1 reference

https://pubmed.ncbi.nlm.nih.gov/6236748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.26.1.94

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28365998&oldid=2139364013"